Get started
Author

Yuki Kuchitsu

Observed names: KUCHITSU, Yuki, Yuki KUCHITSU
Institution: Kitasato University
ORCID: 0009-0003-9034-6418
Observed ORCID: 0009-0003-9034-6418
OpenAlex ID: A5001332459
Prognostic significance of G6PD expression and localization in lung adenocarcinoma
2018 · Ryo Nagashio, Shota Oikawa, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 49
Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer
2018 · Kengo Yanagita, Ryo Nagashio, et al. · American Journal Of Pathology · 42
PDF
Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma
2020 · Ryo NAGASHIO, Yuki KUCHITSU, et al. · Biomedical Research · 24
PDF
Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model
2016 · Kazuyuki Ikeda, Yasutaka Mizoro, et al. · Circulation Journal · 16
PDF
TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma
2020 · Yuki KUCHITSU, Ryo NAGASHIO, et al. · Biomedical Research · 13
PDF
Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
2021 · Seiichiro Kusuhara, Satoshi Igawa, et al. · Thoracic Cancer · 9
Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease
2017 · Chinatsu Suzuki, Akihiro Nakamura, et al. · Clinical Immunology · 9
Proteome analysis using the cancer stem cell-like micropapillary adenocarcinoma cell line
2017 · Ryo Nagashio, Daisuke Hagiuda, et al. · SEIBUTSU BUTSURI KAGAKU · 1
PDF
Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity
2026 · Takashi Sato, Junko Hamamoto, et al. · Lung Cancer
Acquisition of diagnosis markers for lung adenocarcinoma by shotgun analysis targeting membrane proteins
2023 · Yuki Kuchitsu, Nanae Nishihara, et al. · SEIBUTSU BUTSURI KAGAKU
PDF
Acquisition of diagnostic and prognostic markers for lung cancers using antibody-based proteomics
2023 · Ryo Nagashio, Yuki Kuchitsu · SEIBUTSU BUTSURI KAGAKU
PDF
Diagnostic significance of NAP1L1 expression in patients with lung adenocarcinoma
2022 · Ryo Nagashio, Yuki Kuchitsu · SEIBUTSU BUTSURI KAGAKU
PDF
Search of sero-diagnostic marker using the Reverse-phase protein array
2017 · Kengo Yanagita, Daisuke Hagiuda, et al. · SEIBUTSU BUTSURI KAGAKU
PDF
Application of markers obtained by various proteomic methods to resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy
2017 · Yuichi Sato, Ryo Nagashio, et al. · SEIBUTSU BUTSURI KAGAKU
PDF
Detection method for membranous proteins and their utility as a sero-diagnostic markers for lung cancer
2017 · Kengo Yanagita, Daisuke Hagiuda, et al. · SEIBUTSU BUTSURI KAGAKU
PDF
Abstract 69: Possible Involvement Of Proline-rich Tyrosine Kinase 2 (pyk2) In The Pathogenesis Of Kawasaki Disease
2015 · Chinatsu Suzuki, Akihiro Nakamura, et al. · Circulation
Abstract 190: Continuous Vascular Remodeling Related To Development Of Arteriosclerosis Or Atherosclerosis In Kawasaki Disease ~ Immunohistochemical Study using an Animal Model ~
2015 · Kenji Hamaoka, Maiko Fujii, et al. · Circulation
Abstract O.22: Analysis of The Mechanisms of Intravenous Immunoglobulin-resistant Kawasaki Disease Using iPS Cell Technology
2015 · Kazuyuki Ikeda, Tomonaga Ameku, et al. · Circulation
Abstract 59: New findings implicated in Coronary calcification in Chronic phase Kawasaki disease
2015 · Tomoyo Yahata, Kazuyuki Ikeda, et al. · Circulation
Experimental Immunohistochemical Study on Persistent Vascular Remodeling Related to Development of Arteriosclerosis or Atherosclerosis in Chronic Kawasaki Disease Patients
2015 · Kenji Hamaoka, Maiko Fujii, et al. · Journal of the American College of Cardiology
PDF
Abstract 16564: Analysis of the Mechanisms of Intravenous Immunoglobulin-Resistant Kawasaki Disease Using iPS Cell Technology
2014 · Kazuyuki Ikeda, Tomonaga Ameku, et al. · Circulation
Trap1は完全切除された肺腺癌におけるプラチナ製剤を基本とした術後補助化学療法の効果予測マーカーである
· KUCHITSU, Yuki · Institutional Repositories DataBase (IRDB)
Works count: 22
Citation count: 163
H-index: 7
I10-index: 5
Year
Topic
Type